乙烯系单体自由基聚合的阻聚效应——ⅩⅣ.4-甲基丙烯酰氧基-2,2,6,6-四甲基哌啶-1-氧自由基低聚物的合成及对丙烯酸阻聚的研究

 研究了数均分子量10³～5×10³的聚甲基丙烯酸甲酯的制备及其在甲醇镁存在下和2,2,6,6-四甲基-4-羟基哌啶-1-氧自由基(TMHPO·)间的酯交换反应,合成了聚-4-甲基丙烯酰氧基-2,2,6,6-四甲基哌啶-1-氧自由基(PMTMPO·)低聚物。同时观察了4-甲基丙烯酰氧基2,2,6,6-四甲基哌啶的调聚反应,同样制得PMTMPO·低聚物。利用IR、EPR和TGA技术对PMTMPO·进行了表征。评价了PMTMPO·对AIBN引发的丙烯酸(AA)自由基聚合的影响,表明PMTMPO·对AA有良好的阻聚功效。     

两亲嵌段共聚物聚乙二醇-聚谷氨酸苄酯纳米粒药物载体的合成研究

用磺酸酯法制备单端氨基聚乙二醇引发剂,引发谷氨酸苄酯羧酸酐开环聚合,生成可生物降解的两亲嵌段共聚物聚乙二醇﹣聚谷氨酸苄酯(PEG-PBLG),用IR,NMR和GPC表征了共聚物。用超微透析法制备PEG-PBLG聚合物纳米粒,荧光芘探针法测定纳米粒的临界聚集浓度(cac)。紫外分光光度计考察纳米粒对疏水性药物的增溶作用,PEG-PBLG可作为亚微粒药物输送系统的载体。     

具有平整表面的定向纳米碳管膜的制备

为了获得表面平整的定向纳米碳管，通过化学及物理的方法将纳米碳管膜进行反转，使其原来的AAO模板底面成为新的表面，用溶液逐步去除表面的铝和氧化铝后，获得了平整的定向纳米碳管膜表面，从而可将其作为工作面使用. 还比较了5％NaOH和6%H₃PO₄＋1.8%H₂CrO₄溶液去除氧化铝的效果.     

丙烯在ZSM-5沸石上齐聚反应的研究 Ⅰ. 模板剂用量对丙烯齐聚反应的影响

考察了不同正丁胺（NBA）模板剂用量合成ZSM-5沸石的物化特性和催化性能。采用XRD、SEM、NH3-TPD和BET等手段对合成样品的物化特性进行了表征。结果表明，模板剂与SiO2摩尔比在0.67～0.22时合成的ZSM-5沸石结晶度高于90%；随着模板剂用量的减少，ZSM-5沸石的平均粒径减小，强酸量也存在相同的趋势。丙烯齐聚反应评价结果显示,模板剂用量对合成ZSM-5沸石的催化活性有显著影响，模板剂与SiO2摩尔比在0.67～0.45之间合成的沸石催化性能较好。     

Phenolic compounds from Anaphalis aureo-punctata

From the ethanolic extract of the whole plant of Anaphalis aureo-punctata, a new acylated flavonoid glycoside 3-O-kaempferol-3-O-acetyl-6-O-(p-coumaroyl)-β-D-glucopyranoside (1), and five known phenolic compounds 3-O-kaempferol-6- O- ( p-coumaroyl )-β-D-glucopyranoside ( 2 ), kaempferol-3- O-β-D-glucopyranoside 3,6-(4′-hydroxystyryl)-4-methoxy-2-pyrone (4), 2H-pyran-2-one, 6-[ 2-( 4-(β-D-glucopyranosyloxy ) phenyl ) ethenyl ]-4-methoxy-( E ) (5) and 4-hydroxy-3-methoxycinnamic hexacosyl ester (6) were isolated. Their structures were established by spectral methods (UV, IR, MS, 1D, 2D-NMR). The flavonoid glycosides, 1, 2 and 3 showed markedly inhibited oxidative DNA strand breaks induced by Fenton reaction and NADH/PMS in a concentration-dependent manner.     

STUDIES ON POLYVINYL ALCOHOL CARRIERS Ⅲ. ACTIVE AMIDES AND ESTERS DERIVED FROM POLYVINYL ALCOHOL AND THEIR APPLICATION IN AFFINITY CHROMATOGRAPHY

Polyvinyl alcohol carriers bearing active amide and active ester groups were prepared by acetaliza-tion of granular macro-reticular water-insolub1e PVA with glyoxylic acid or p-formylbenzoic acidand further activation reaction with benzotriazole or N-hydroxysuccinimide using DCCI as con-densation agent. The active amides or active esters obtained were easy to react with amines suchas n-butylamine or proteins under mild condition. Ovomucoid, an inhibitor of trypsin was immo-bilized on the above-obtained reactive PVA carrier to give effective affinity adsorbent for the separa-tion or purification of trypsin.     

CdSe纳米线阵列的制备及其表征(英)

通过在含有SeSO₃^2-和Cd²⁺的室温水溶液中，用模板-电沉积法在纳米孔阵列阳极氧化铝膜(AAM)模板中制备了高有序性的CdSe纳米线阵列，并对其形貌、结构和组分进行了表征。扫描电子显微镜(SEM)和透射电子显微镜(TEM)结果表明，纳米线阵列中的CdSe纳米线具有相同的长度和直径，分别对应于使用的AAM模板的厚度和孔径；X-射线衍射(XRD)和X-射线能谱(EDAX)结果表明，CdSe纳米线中Cd和Se的化学组成非常接近于1∶1，其结构为立方CdSe。另外，对模板-电沉积法制备CdSe纳米线的机理进行了讨论。     

A New Asterosaponin from the Starfish Culcita novaeguineae

A new asterosaponin named novaeguinoside A, along with a known saponin, asteronyl pentaglycoside sulfate, was isolated from the starfish Culcita novaeguineae. The new compound was identitied to be sodium 6α-O-{β-D-fucopyranosyl-(1→2)-β-D-fucopyranosyl-(1→4)-[β-D-quinovopyranosyl-(1→2)]-β-D-xylopyranosyl-(1→3)-[β-D-quinovopyranosyl}-5α-pregn-9(11)-en-20-one-3β-yl-sulfate by extensive spectral analysis and chemical evidence.     

具有生物活性的N-(1-二茂铁亚乙基氨基)-N''-β-D-吡喃糖基硫脲的合成与表征

Several novel N′-[（1-ferrocenylethylidene）amino]-N′-β-D-glycopyranosylthioureas have been efficiently synthesized via a six-step procedure, utilizing three monosaccharides （D-glucose, D-galactose and D-xylose） as starting materials, respectively. They have been preliminarily determined to display biological activity against certain fungi. The target compounds have been unambiguously characterized by spectroscopic method and elemental analysis. An initially alternative synthetic route, which was seemingly reasonable, has been excluded due to its inefficiency.     

哌嗪取代卟啉的合成、表征及其抗癌活性

设计并合成了6个具有抗癌活性的哌嗪取代卟啉化合物,分别为5,10,15,20-四[4-(4'-乙基哌嗪基)苯基]卟啉(TEPPH2,8a),5,10,15,20-四[4-(4'-丁基哌嗪基)苯基]卟啉(TBPPH2,8b),5,10,15,20-四[4-(4'-庚基哌嗪基)苯基]卟啉(THPPH2,8c),5,10,15,20-四[4-(4'-苯基哌嗪基)苯基]卟啉(TPhPPH2,8d),5-[4-(4'-乙基哌嗪基)苯基]-10,15,20-三苯基卟啉(EPTPPH2,8e)和5-[4-(4'-丁基哌嗪基)苯基]-10,15,20-三苯基卟啉(BPTPPH2,8f).这些卟啉化合物都由取代苯甲醛与吡咯缩合而成,每一个卟啉分子中含有一个或四个具有抗癌活性的取代哌嗪结构,结构经元素分析,MS,1H NMR,IR和UV-vis等表征.初步的生物活性研究表明,这些化合物具有一定的抗癌活性,因而在医学上可能具有潜在应用前景.